Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 2/20 | 0.32 |
| ▸ | ADH1A | P07327 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | SHBG | P04278 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1482415 | 1.00 | CYP1A2 (0.44) | CYP1A2TSHRALDH1A1NAAAADH1A | |
| SCHEMBL1482398 | 1.00 | CYP1A2 (0.44) | CYP1A2TSHRALDH1A1NAAAADH1A | |
| SCHEMBL23261 | 0.98 | CYP1A2 (0.41) | CYP1A2TSHRALDH1A1NAAAADH1A | |
| SCHEMBL1481768 | 0.93 | CYP1A2 (0.43) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL669962 | 0.93 | CYP1A2 (0.43) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL1481940 | 0.93 | CYP1A2 (0.43) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL919373 | 0.93 | — | — | |
| SCHEMBL8769510 | 0.91 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL22042671 | 0.91 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 | |
| SCHEMBL22042665 | 0.91 | CYP1A2 (0.41) | CYP1A2TSHRNAAAEPHX1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 345 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240188441-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-06-06 | — | — | US | claimed |
| EP-3688124-B1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-10-25 | — | — | EP | claimed |
| CN-116848094-A | Tertiary amine lipid compounds and uses thereof | 华南理工大学 | 2023-10-03 | — | — | CN | claimed |
| EP-3688124-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | ExxonMobil Chemical Patents Inc. (US) | 2020-08-05 | — | — | EP | claimed |
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-07-14 | — | — | US | claimed |
| CN-111386331-A | Ester compound, lubricating oil composition containing same, and method for producing same | 埃克森美孚化学专利公司 | 2020-07-07 | — | — | CN | claimed |
| EP-2504288-B1 | OPTICAL FIBER WITH DOUBLE COATING | PRYSMIAN SPA (IT) | 2019-04-17 | — | — | EP | claimed |
| WO-2019067061-A1 | ESTER COMPOUNDS, LUBRICATING OIL COMPOSITIONS CONTAINING SAME AND PROCESSES FOR MAKING SAME | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2019-04-04 | — | — | WO | claimed |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-04-04 | — | — | US | claimed |
| EP-2504288-A1 | OPTICAL FIBER WITH DOUBLE COATING | Prysmian S.p.A. (IT) | 2012-10-03 | — | — | EP | claimed |
| EP-0651739-B1 | HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARM (GB) | 1997-04-09 | — | — | EP | claimed |
| EP-0694036-B1 | HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARM (GB) | 1997-03-05 | — | — | EP | claimed |
| EP-0754688-A2 | Dioxolane intermediates | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1997-01-22 | — | — | EP | claimed |
| EP-0694036-A1 | HYDROXAMIC ACID DERIVATIVES | BRITISH BIOTECH PHARM (GB) | 1996-01-31 | — | — | EP | claimed |
| EP-0651739-A1 | HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS. | BRITISH BIOTECH PHARM (GB) | 1995-05-10 | — | — | EP | claimed |
| EP-0651738-A1 | NATURAL AMINO ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-05-10 | — | — | EP | claimed |
| WO-1994024140-A1 | HYDROXAMIC ACID DERIVATIVES | BRITISH BIO-TECHNOLOGY LIMITED (GB) | 1994-10-27 | — | — | WO | claimed |
| WO-1994002446-A1 | NATURAL AMINO ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1994-02-03 | — | — | WO | claimed |
| WO-1994002447-A1 | HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1994-02-03 | — | — | WO | claimed |
| US-4548818-A | Composition and methods for the treatment of chronic obstructive airway disease and cardiac disease using 3-alkylxanthines | AKTEBOLAGET DRACO, A COMPANY OF SWEDEN (SE) | 1985-10-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10711216-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | ELOVL1, NOTUM, ELOVL5 | CYP1A2 913/4885TSHR 4714/4885ALDH1A1 476/4885 |
| US-20240188441-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE CONDENSED CYCLIC COMPOUND | CRY1, ELP1, CCNE2 | CYP1A2 1017/4885TSHR 4416/4885ALDH1A1 236/4885 |
| US-20190100710-A1 | Ester Compounds, Lubricating Oil Compositions Containing Same and Processes for Making Same | ELOVL1, NOTUM, ELOVL5 | CYP1A2 913/4885TSHR 4714/4885ALDH1A1 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.